Auxilium Pharmaceuticals, Inc. (AUXL) Tops Q3 EPS Views

October 31, 2011 7:01 AM EDT
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) reported Q3 EPS of ($0.08), $0.13 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $66.7 million versus the consensus estimate of $66.83 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings